Author: Wadei, Hani M.; Gonwa, Thomas A.; Leoni, Juan C.; Shah, Sadia Z.; Aslam, Nabeel; Speicher, Leigh L.
Title: COVIDâ€19 infection in solid organ transplant recipients after SARSâ€CoVâ€2 vaccination Cord-id: uxduueho Document date: 2021_5_18
ID: uxduueho
Snippet: The prevalence and mortality of COVID-19 are higher in solid organ transplant recipients (SOTs) compared to the general population (1-3). Two SARS-CoV-2 messenger RNA (mRNA) vaccines have been approved by the FDA, both are 95% efficient in preventing COVID-19 in the general population. The efficacy of these vaccines in SOTs remains to be unknown as immunocompromised patients have been excluded from the vaccine studies.
Document: The prevalence and mortality of COVID-19 are higher in solid organ transplant recipients (SOTs) compared to the general population (1-3). Two SARS-CoV-2 messenger RNA (mRNA) vaccines have been approved by the FDA, both are 95% efficient in preventing COVID-19 in the general population. The efficacy of these vaccines in SOTs remains to be unknown as immunocompromised patients have been excluded from the vaccine studies.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date